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Oral verruciform xanthoma (VX) is an uncommon
oral mucosal lesion that was first described by
Shafer in 1971.1 The frequency of occurrence is
approximately 0.025%.2 Up to 2001, a total of 282
cases of oral VX have been reported.3 Oral VXs
occur more often in middle-aged patients with a
mean age of 51 years.4,5 There was a slight male
predilection in the largest series of 282 cases re-
ported.3 The most frequent site of occurrence is
the gingiva.3,4
Clinically, oral VX appears as a small, asymp-
tomatic, verrucous, papillary, or flat lesion with a
white, yellow-white, or red color depending on the
degree of surface keratinization and the number
of lipid-laden macrophages in the connective 
tissue papillae.6 The papillary or verrucous outer
appearance of the lesion with a broad or pedun-
culated base often leads to a clinical misdiagno-
sis of papilloma, verrucous hyperplasia, verrucous
carcinoma, or squamous cell carcinoma (SCC).7
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Background/Purpose: Oral verruciform xanthoma (VX) is an uncommon oral mucosal lesion. This retrospec-
tive study evaluated the clinical and histopathologic features of 15 oral VXs occurring in Taiwanese patients.
Methods: Fifteen consecutive cases of oral VX were collected from January 1988 to December 2005.
Clinical data and microscopic features of these cases were reviewed and analyzed.
Results: The mean age of patients was 45 years (range, 18–79 years). There were eight male and seven 
female patients. Seven (46.6%) cases occurred on the gingiva, four (26.7%) on the tongue, and four
(26.7%) on the buccal or vestibular mucosa. The greatest mean dimension of the lesions was 0.8 cm
(range, 0.3–2.0 cm). Three patients had concomitant other oral mucosal lesions such as oral submucous
fibrosis, squamous cell carcinoma, and erosive oral lichen planus. Microscopically, all specimens showed
varying degrees of surface parakeratosis and the accumulation of numerous foam cells in the connective
tissue papillae among uniformly elongated epithelial ridges. Individuals or aggregates of foam cells were
also found underneath the epithelial ridges in nine (60%) cases. When the oral VX lesions were further
classified into three types according to the microscopic surface architecture, seven (47%) lesions were of
the verrucous type, three (20%) the papillary type, and five (33%) the flat type. All patients received surgi-
cal excision of the lesions and no recurrence was noted during follow-up of up to 18 years.
Conclusion: Oral VXs occur more frequently in the fifth decade of life. The more commonly affected site
is the gingiva. The treatment of choice for oral VXs is surgical excision. The prognosis is excellent and 
recurrence was not seen in this study. [J Formos Med Assoc 2007;106(2):141–147]
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Microscopically, the lesion is characterized 
by varying degrees of parakeratosis, parakeratin
plugging, and numerous foam or xanthoma 
cells accumulated within the connective tissue
papillae among uniformly elongated epithelial
ridges.6
The etiology and pathogenesis of oral VX 
remain unclear, while inflammatory,8 viral,9 and
immunologic10 factors have been suggested. Viral
factor is less likely because in situ hybridization
study shows that < 10% of VX specimens are
human papillomavirus (HPV) DNA-positive and
none of the VX specimens are HPV antigen-
positive.5 Although several large-series studies of
oral VX have been reported in the West, only two
cases of oral VX have been reported from Taiwan
in the English literature.11 Therefore, the purposes
of this study were to describe the clinical and
histopathologic features of 15 oral VXs occurring
in Taiwanese patients and to compare our results
with those from previous studies.
Methods
The study group consisted of 15 cases of oral VX
retrieved from the files of the Department of Oral
Pathology and Oral Diagnosis, National Taiwan
University Hospital, Taipei, from January 1988
to December 2005. All lesions received an exci-
sional biopsy. The biopsy specimens were fixed in
10% neutral formalin for at least 24 hours, dehy-
drated in graded alcohol, and then embedded in
paraffin. The paraffin-embedded tissue blocks were
cut in serial sections of 5 μm, which were then
stained with hematoxylin and eosin (H&E) and
examined by microscopy. Histopathologic diagno-
sis of the lesion was based on examination of 
the H&E-stained tissue sections.
The characteristic microscopic criteria for diag-
nosis of oral VXs included parakeratotic, acanthotic
epithelium with verrucous, papillary, or flat outer
surface, uniformly elongated epithelial ridges, and
the accumulation of a large number of lipid-laden
macrophages (xanthoma cells) in the connec-
tive tissue papillae.12 The oral VXs were further
classified into three types according to the micro-
scopic surface architecture proposed by Nowparast
et al:4 type A (verrucous), type B (papillary), and
type C (flat).
Data on patients’ age, gender, location and size
of lesion, clinical diagnosis, treatment, and oral
habits (OHs) of the patients were obtained by 
reviewing the dental charts. Other oral mucosal
lesions occurring concomitantly with oral VXs
were also recorded.
Results
The clinical data of the 15 oral VXs are presented 
in Table 1. The mean age of patients at the time of
diagnosis was 45 years (range, 18–79 years).
There were eight male and seven female patients.
Of the 15 VXs, seven (46.6%) occurred on the
gingiva (4 on mandibular and 3 on maxillary
gingivae), four (26.7%) on the tongue (Figure 1,
patient 13), and four (26.7%) on the buccal or
vestibular mucosa. The greatest mean dimension
of the lesions was 0.8 cm (range, 0.3–2.0 cm).
Only three lesions were correctly diagnosed as
oral VX at the time of initial clinical presentation.
Verrucous hyperplasia (5 cases) was the most
common initial clinical diagnosis, followed by
papilloma or papillomatous lesion (3 cases), ul-
cerative lesion (2 cases), fibroepithelial polyp (1
case), and exophytic mass (1 case) (Table 1).
Data on OHs (alcohol drinking, areca quid
chewing, cigarette smoking) were available for
13 patients. Seven patients had no OH and six
had at least 1 OH (3 with 3 OHs, 1 with 2 OHs,
and 1 with 1 OH) (Table 1). Three patients had
concomitant oral mucosal lesions such as oral
submucous fibrosis (OSF), SCC, and erosive 
oral lichen planus (EOLP) at independent sites.
All patients received excision of the lesion and
no recurrence was noted during follow-up of up
to 18 years.
The histopathologic features of the 15 oral
VXs are summarized in Table 2. All 15 specimens
showed varying degrees of surface parakeratosis
and the accumulation of numerous foam cells in
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the connective tissue papillae among uniformly
elongated epithelial ridges (Figure 2A). Parakeratin
plugs were also frequently found extending from
the surface into the crypts formed by epithelial
projections (Figure 2B). Although foam cells were
uniformly found in the connective tissue papillae
in every VX case, individuals or aggregates of addi-
tional foam cells were also found underneath the
epithelial ridges in nine (60%) cases. When the
15 lesions were further classified into three types
according to the microscopic surface architecture,
seven (47%) lesions were of the verrucous type
(Figure 2B), three (20%) the papillary type
(Figure 2C), and five (33%) the flat type (Figures
2D and 2E).
There were varying degrees of acute or chronic
inflammatory cell infiltrate in the subepithelial
Oral verruciform xanthoma
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Figure 1. Clinical photograph showing a slightly elevated
yellowish verruciform xanthoma on the right ventral surface
of the tongue (patient 13 in Table 1).
Table 1. Age, gender, location and size of lesion, clinical diagnosis, and oral habits of 15 patients with oral verruciform 
xanthoma
Patient Age (yr) Gender Location Size (cm) Clinical diagnosis Oral habits
1 31 M Palatal gingiva of #25 and #26 0.5 × 0.3 Verruciform xanthoma A+ B– C–
2 42 F Left dorsal surface of tongue 1.0 × 0.8 Verrucous hyperplasia A– B– C–
3 48 M Buccal gingiva of #21 and #22 0.3 × 0.3 Papillomatous lesion Unavailable
4 28 M Right buccal mucosa 2.0 × 1.0 Verrucous hyperplasia A+ B+ C+
5 51 F Buccal gingiva of #45 0.5 × 0.3 Papilloma A– B– C–
6 43 M Buccal gingiva of #36 and #37 0.7 × 0.5 Ulcerative lesion A– B+ C+
7 39 M Palatal gingiva of #27 0.7 × 0.5 Verrucous hyperplasia A+ B+ C+
8 56 M Right ventral surface of tongue 0.6 × 0.4 Ulcerative lesion A+ B+ C+
9 79 F Right buccal mucosa 0.5 × 0.5 Fibroepithelial polyp A– B– C–
10 46 F Vestibular mucosa of #25 and #26 area 1.0 × 1.0 Papilloma A– B– C–
11 44 M Buccal gingiva of #46, #47 and #48 1.5 × 0.5 Verrucous hyperplasia Unavailable
12 46 M Left dorsal surface of tongue 0.6 × 0.6 Exophytic mass A+ B+ C+
13 18 F Right ventral surface of tongue 0.8 × 0.5 Verruciform xanthoma A– B– C–
14 32 F Buccal gingiva of #36 0.4 × 0.2 Verrucous hyperplasia A– B– C–
15 72 F Right buccal mucosa 0.6 × 0.6 Verruciform xanthoma A– B– C–
A = alcohol drinking; B = areca quid chewing; C = cigarette smoking.
Table 2. Histopathologic features 15 oral VXs
Inflammation/
Additional foam
Patient Histologic type
subpopulations
cells underneath
epithelial ridges
1 Papillary Mild/L, P −
2 Verrucous Moderate/L, P, N ++
3 Verrucous Mild/L, P +
4 Flat Moderate/L, P, N +
5 Flat Moderate/L, P +
6 Verrucous Mild/L, P −
7 Verrucous Mild/L, P −
8 Flat Severe/L, P, +
germinal center
9 Verrucous Mild/L, P +
10 Papillary Severe/L, P, N, ++
germinal center
11 Verrucous Severe/L, P, E, −
germinal center
12 Flat Mild/L, P, N +
13 Flat Mild/L, P, N, E +
14 Verrucous Mild/L, P, N −
15 Papillary Moderate/L, P, N −
L = lymphocyte; P = plasma cell; N = neutrophil; E = eosinophil.
connective tissue. Of the 15 lesions, eight had
mild, four had moderate, and three had severe de-
grees of inflammation. In the three lesions with
severe inflammation, lymphocytes had aggregated
to form germinal centers in the lamina propria
(Figure 2E). Chronic inflammatory cell infiltrate
composed mainly of lymphocytes and plasma
cells was noted in all 15 lesions. Acute inflamma-
tory cell infiltrate composed predominantly of
neutrophils and eosinophils was found in eight
lesions. Only one lesion presented a neutrophil-
dominant infiltrate. In the other seven lesions,
neutrophils or eosinophils were sparely distrib-
uted among chronic inflammatory cells.
Discussion
The mean age of our 15 patients with oral VX
was 45 years and six (40%) of our 15 patients
were in their fifth decade of life. Several previous
studies also noted that the mean age of patients
with oral VX was between 40 and 49 years.2,13–15
However, mean patient ages of older than 49
years or younger than 40 years have also been re-
ported.3–5,16,17 The discrepancy in the mean age
of patients may be due to differences in the race
of patients and sample size.
In this study, oral VXs occurred nearly evenly
in males and females. Two previous studies also
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Figure 2. Histologic photographs of oral verruciform xan-
thoma. (A) High-power view of an oral verruciform xanthoma
showing the accumulation of numerous foam cells in the
connective tissue papillae (100×). (B) A verrucous-type ver-
ruciform xanthoma demonstrating parakeratin plugs extend-
ing from the surface into the crypts formed by epithelial
projections (25×). (C) A papillary-type verruciform xanthoma
(25×). (D) A flat-type verruciform xanthoma (25×). (E) A flat-
type verruciform xanthoma showing a severe infiltrate of
lymphocytes that have formed germinal centers in the lamina
propria (10×). (All hematoxylin & eosin.)
demonstrated an equal gender distribution of
patients with oral VX.2,16 However, most previ-
ous studies showed either a slight male predilec-
tion3–5,14,15,17 or a female predominance13 for the
occurrence of oral VXs. The differences in gender
distribution of patients among these studies may
suggest that there is probably no significant gen-
der predilection in patients with oral VX.
In the largest series of 282 cases of oral VXs
reported by Philipsen et al,3 the most commonly
affected site was the gingiva (57.4%), followed
by the tongue (10.3%), hard palate (7.1%), buccal
or vestibular mucosa (6.7%), floor of the mouth
(4.6%), and soft palate (3.2%). Other studies in-
cluding ours also showed that the most common
site was the gingiva.2,4,13,14,16,17 The size of oral VXs
was usually between 0.2 and 2.0 cm,2,4,5,13,14,16
with the exception of the largest lesion measuring
4.0 × 1.5 cm documented by Graff et al.18 A com-
parable result in lesion size was also found in
this study.
In the present study, only 20% (3/15) of oral
VXs were correctly diagnosed at the time of initial
presentation. Because oral VXs usually showed
verrucous or papillary outer appearance, they were
frequently misdiagnosed as verrucous hyperplasia
(5 cases) and papilloma or papillomatous lesions
(3 cases) in this study. It should be noted by the
clinician that in our series oral VXs may have 
surface ulceration (2 cases) or may look like a 
fibroepithelial polyp (1 case).
Several previous studies reported an associa-
tion of a previously occurring or a concomitant
oral mucosal lesion with oral VX. These lesions
include lichen planus,19–21 pemphigus vulgaris,22
carcinoma in situ,7 and SCC.13 In our series, there
were three oral VXs that developed in association
with a concomitant oral mucosal lesion such as
OSF (patient 4), SCC (patient 8), and EOLP 
(patient 15). The nature of the simultaneous 
occurrence of the lesions with oral VXs was not
clear, but evidence of oral VX being a precancer-
ous lesion has never been reported.3
There was only one report showing the asso-
ciation of OHs with the occurrence of oral VXs.
Neville and Weathers13 reported a 65-year-old 
female snuff user who presented with an oral VX
at the mandibular alveolar mucosa and an SCC at
the floor of the mouth. In the present study, five
patients were alcohol drinkers, five were areca quid
chewers, and five were cigarette smokers. Because
of the limited data on OHs in previously reported
cases and the small sample size in this study, we
could not draw a conclusion on the association
of OHs with the occurrence of oral VXs.
Nowparast et al classified oral VXs into three
types (verrucous, papillary, flat) according to the
microscopic surface architecture of the lesions.4
In their series of 54 oral VXs, there were 24 (44%)
lesions of the verrucous type, 17 (32%) of the
papillary type, and 13 (24%) of the flat type. This
study also showed that the verrucous type (7 cases,
47%) was the most common microscopic type.
However, the flat type (5 cases, 33%) was the next
most common and the papillary type (3 cases,
20%) was the least common.
The striking feature of oral VX is the accumula-
tion of numerous foam cells (xanthoma cells) of
varying sizes in connective tissue papillae. Previous
studies have shown that these foam cells contain
both lipid6,8,23 and periodic acid-Schiff (PAS)-
positive, diastase-resistant granules in their cyto-
plasm.6,13 The origin of foam cells was found to
be macrophages, because these foam cells are
CD-68-positive6,15,17 and contain cathepsin B in
their cytoplasm.5
The etiology and pathogenesis of VX remains
unclear. Based on light and electron microscopic
studies, Zegarelli et al proposed that foam cells
are lipid-laden macrophages and oral VX may
develop as a consequence of epithelial entrapment
with subsequent degeneration and lipid accumu-
lation.8 They suggested a local irritant as the ini-
tiator of the disease process because oral VX is
frequently found on masticatory mucosa where
localized trauma is very common.8,9 Nowparast
et al suggested that the verrucous and papillary
architecture may be secondary to the presence of
foam cells, which affect the nutrient and metabo-
lism of the epithelial cells, leading to hyperparak-
eratotic change.4 Iamaroon and Vickers studied
12 cases of VX by in situ hybridization and 
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immunohistochemistry.5 They found that only
one of the 12 VX specimens was positive for HPV
types 6/11 by in situ hybridization. None of the 12
specimens demonstrated the presence of HPV
antigen by immunohistochemistry. Moreover,
the predominant cells in the inflammatory infil-
trate were T cells (51.8±2%), and 43.3±2% of 
inflammatory cells were positive for HLA-DR
antigens. They suggested that an immune response
may play a role in VX pathogenesis. Rowden et al
demonstrated the presence of Langerhans cells
in VX lesions by anti-S-100 immunostaining and
suggested an immunologic pathogenesis for VXs.10
Mostafa et al suggested that VX may be a local 
T-cell-mediated immunologic disorder.17 Oliveira
et al suggested that the pathologic process of VXs
may be based on an immunologic response similar
to that of lichen planus.15 In addition, this study
showed a universal presence of lymphocytes and
plasma cells in all 15 oral VX lesions, the occur-
rence of all 15 oral VX lesions on easily trauma-
tized mucosae such as gingiva, tongue, and buccal
mucosa, the association of OHs with 46% (6/13)
of oral VX lesions, and concomitant presence of
oral epithelial lesions such as OSF, SCC, and EOLP
in association with three oral VX lesions. Based on
the findings from previous and present studies,
we suggest that oral VX lesions may represent an
immune-associated response to localized epithelial
trauma or damage, resulting in the release of
membranous lipid components into the adjacent
connective tissue, phagocytosis of lipids by tissue
macrophages, and the accumulation of lipid-laden
macrophages in connective tissue papillae.
The treatment for oral VX is surgical excision
and the prognosis is excellent.3 Recurrence is ex-
tremely rare. To date, only three recurrent cases
have been reported in the literature, all located at
the palate.4,5,24 In our series, all patients received
surgical excision of oral VX lesions and no recur-
rence was observed during a follow-up of up to
18 years. In conclusion, oral VXs occur more fre-
quently in the fifth decade of life. The most com-
monly affected site is the gingiva. The treatment of
choice for oral VXs is surgical excision. The prog-
nosis is excellent and recurrence is extremely rare.
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